These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 34406906)

  • 1. Effect of racial background on motor cortical function as measured by threshold tracking transcranial magnetic stimulation.
    Suzuki YI; Ma Y; Shibuya K; Misawa S; Suichi T; Tsuneyama A; Nakamura K; Matamala JM; Dharmadasa T; Vucic S; Fan D; Kiernan MC; Kuwabara S
    J Neurophysiol; 2021 Sep; 126(3):840-844. PubMed ID: 34406906
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Distinct neuronal circuits mediate cortical hyperexcitability in amyotrophic lateral sclerosis.
    Pavey N; Hannaford A; van den Bos M; Kiernan MC; Menon P; Vucic S
    Brain; 2024 Jul; 147(7):2344-2356. PubMed ID: 38374770
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cortical excitability varies across different muscles.
    Menon P; Kiernan MC; Vucic S
    J Neurophysiol; 2018 Sep; 120(3):1397-1403. PubMed ID: 29975162
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inter-session reliability of short-interval intracortical inhibition measured by threshold tracking TMS.
    Matamala JM; Howells J; Dharmadasa T; Trinh T; Ma Y; Lera L; Vucic S; Burke D; Kiernan MC
    Neurosci Lett; 2018 May; 674():18-23. PubMed ID: 29501687
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reduction in short interval intracortical inhibition from the early stage reflects the pathophysiology in amyotrophic lateral sclerosis: A meta-analysis study.
    Higashihara M; Pavey N; Menon P; van den Bos M; Shibuya K; Kuwabara S; Kiernan MC; Koinuma M; Vucic S
    Eur J Neurol; 2024 Jul; 31(7):e16281. PubMed ID: 38504632
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Riluzole exerts central and peripheral modulating effects in amyotrophic lateral sclerosis.
    Vucic S; Lin CS; Cheah BC; Murray J; Menon P; Krishnan AV; Kiernan MC
    Brain; 2013 May; 136(Pt 5):1361-70. PubMed ID: 23616585
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cortical excitability testing distinguishes Kennedy's disease from amyotrophic lateral sclerosis.
    Vucic S; Kiernan MC
    Clin Neurophysiol; 2008 May; 119(5):1088-96. PubMed ID: 18313980
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differences between Han Chinese and Caucasians in transcranial magnetic stimulation parameters.
    Yi X; Fisher KM; Lai M; Mansoor K; Bicker R; Baker SN
    Exp Brain Res; 2014 Feb; 232(2):545-53. PubMed ID: 24240390
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Defining the mechanisms that underlie cortical hyperexcitability in amyotrophic lateral sclerosis.
    Vucic S; Cheah BC; Kiernan MC
    Exp Neurol; 2009 Nov; 220(1):177-82. PubMed ID: 19716820
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effect of coil type and limb dominance in the assessment of lower-limb motor cortex excitability using TMS.
    Dharmadasa T; Matamala JM; Howells J; Simon NG; Vucic S; Kiernan MC
    Neurosci Lett; 2019 Apr; 699():84-90. PubMed ID: 30710665
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of motor cortical and peripheral axonal hyperexcitability on survival in amyotrophic lateral sclerosis.
    Otani R; Shibuya K; Suzuki YI; Suichi T; Morooka M; Aotsuka Y; Ogushi M; Kuwabara S
    J Neurol Neurosurg Psychiatry; 2024 Jul; 95(8):730-736. PubMed ID: 38418214
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cortical excitability in hereditary motor neuronopathy with pyramidal signs: comparison with ALS.
    Vucic S; Nicholson GA; Kiernan MC
    J Neurol Neurosurg Psychiatry; 2010 Jan; 81(1):97-100. PubMed ID: 20019225
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Four-pulse transcranial magnetic stimulation using multiple conditioning inputs. Normative MEP responses.
    Calancie B; Wang D; Young E; Alexeeva N
    Exp Brain Res; 2018 Apr; 236(4):1205-1218. PubMed ID: 29473092
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A new parameter to discriminate amyotrophic lateral sclerosis patients from healthy participants by motor cortical excitability changes.
    Cengiz B; Kuruoğlu R
    Muscle Nerve; 2020 Mar; 61(3):354-362. PubMed ID: 31875983
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Laterality of motor cortical function measured by transcranial magnetic stimulation threshold tracking.
    Shibuya K; Park SB; Howells J; Huynh W; Noto YI; Shahrizaila N; Matamala JM; Vucic S; Kiernan MC
    Muscle Nerve; 2017 Mar; 55(3):424-427. PubMed ID: 27511622
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cortical excitability distinguishes ALS from mimic disorders.
    Vucic S; Cheah BC; Yiannikas C; Kiernan MC
    Clin Neurophysiol; 2011 Sep; 122(9):1860-6. PubMed ID: 21382747
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Regional motor cortex dysfunction in amyotrophic lateral sclerosis.
    Menon P; Yiannikas C; Kiernan MC; Vucic S
    Ann Clin Transl Neurol; 2019 Aug; 6(8):1373-1382. PubMed ID: 31402622
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Potential structural and functional biomarkers of upper motor neuron dysfunction in ALS.
    Grieve SM; Menon P; Korgaonkar MS; Gomes L; Foster S; Kiernan MC; Vucic S
    Amyotroph Lateral Scler Frontotemporal Degener; 2015; 17(1-2):85-92. PubMed ID: 26458122
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inter-individual variation in the after-effect of paired associative stimulation can be predicted from short-interval intracortical inhibition with the threshold tracking method.
    Murase N; Cengiz B; Rothwell JC
    Brain Stimul; 2015; 8(1):105-13. PubMed ID: 25444589
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cortical excitability differences between flexor pollicis longus and APB.
    Bae JS; Menon P; Mioshi E; Kiernan MC; Vucic S
    Neurosci Lett; 2013 Apr; 541():150-4. PubMed ID: 23499957
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.